Troyelm
Lv4
458 积分
2025-02-25 加入
-
1993-LB: BGM1812, a Novel Amylin Analog, Enhances Receptor Agonism and Induces Superior Weight Loss in Preclinical Models
1天前
求助中
-
88-OR: Long-Acting Amylin Analog AZD6234 in Combination with the GLP-1R Agonist Semaglutide Enhances Body Weight and Fat Mass Loss in Diet-Induced Obese (DIO) Rats
2天前
求助中
-
882-P: Eloralintide, a Selective, Long-Acting Amylin Receptor Agonist for Obesity—Phase 1 Proof of Concept
2天前
已完结
-
In silicodesign and identification of new peptides for mitigating hIAPP aggregation in type 2 diabetes
10天前
已完结
-
Peptide Engineering Approach to Introduce an Improved Calcitonin Mutant
12天前
已完结
-
849-P: Eloralintide (LY3841136), a Selective Amylin Mimetic, Lowered Body Weight with Improved Quality of Weight Loss and GI Tolerability in Rats Compared with Cagrilintide
15天前
已完结
-
Peptide Engineering Approach to Introduce an Improved Calcitonin Mutant
23天前
已关闭
-
Strategies to Enhance the Therapeutic Efficacy of GLP‐1 Receptor Agonists through Structural Modification and Carrier Delivery
24天前
已完结
-
GLP-1R agonists: recent advances, current gaps, and future challenges
24天前
已完结
-
Amylin: Pharmacology, Physiology, and Clinical Potential
1个月前
已完结